Prasad Raju
CRISPR Therapeutics AG-Common Shares · Chief Financial Officer
Prasad Raju is listed in filings as Chief Financial Officer at CRISPR Therapeutics AG-Common Shares. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to CRISPR Therapeutics AG-Common Shares (CRSP). The current snapshot covers public activity from Oct 18, 2024 to Jun 2, 2026. Reported amounts are shown as $173.5K to $282.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $282k5.8k shares | SellMar 16, 2026 | $48.26 | $51.37 | |
| $194k4k shares | SellMar 16, 2026 | $48.26 | $51.37 | |
| $2M35k shares | SellJan 22, 2026 | $60.19 | $51.37 | |
| $1M18.9k shares | SellJan 6, 2026 | $60.18 | $51.37 | |
| $347k5.8k shares | SellJan 6, 2026 | $60.21 | $51.37 | |
| $300k5k shares | SellJan 6, 2026 | $60.00 | $51.37 | |
| $308k5.5k shares | SellDec 22, 2025 | $56.33 | $51.37 | |
| $194k3.5k shares | SellDec 22, 2025 | $55.10 | $51.37 | |
| $57k1k shares | SellDec 22, 2025 | $56.89 | $51.37 | |
| $91k2.2k shares | SellMar 21, 2025 | $41.23 | $51.37 | |
| $157k3.8k shares | SellMar 17, 2025 | $41.80 | $51.37 |